WHO WE ARE
4Dx Limited is an early stage medical technology company based in Melbourne, Australia, established to commercialise four-dimensional lung imaging technology: 4DxV.
Conceived by 4Dx founder Andreas Fouras and developed by his research group, the Laboratory for Dynamic Imaging at Monash University, and the 4Dx team, 4Dx has successfully proven and patented its technology with 10 years of studies and trials completed by some of the most talented minds within the field of medical technology.
Having raised millions of dollars in research funding from agencies including Australia’s National Health & Medical Research Council and the American Asthma Foundation, the team has positioned itself as an unrivalled leader in the race to deliver world changing medical technology breakthroughs.
Human studies have commenced to definitively demonstrate the value of this technology in the radiotherapy setting and represents a significant step towards regulatory approval.
We will advance disease detection, enhance disease management and reach patients with healthcare solutions. We will strive for excellence and influence by participating in markets where we can make a significant contribution to global health.